1. Introduction
===============

Marine bacteria belonging to the genus *Pseudoalteromonas* sp. (family Pseudoalteromonadaceae) have proven to be not only an important source of various antibiotics, but have also played an interesting role in marine ecology \[[@B1-marinedrugs-10-01566],[@B2-marinedrugs-10-01566],[@B3-marinedrugs-10-01566],[@B4-marinedrugs-10-01566]\]. In the continuing research aimed at the discovery of new natural substances from marine microorganisms, an organic extract of the bacterium identified as *Pseudoalteromonas* sp. CGH2XX, which was originally isolated from a cultured-type octocoral *Lobophytum crassum* (family Alcyonacea), exhibited significant cytotoxicity toward the HL-60 (human acute promyelocytic leukemia) and CCRF-CEM (human T cell acute lymphoblastic leukemia) tumor cells (IC~50~ = 0.9, 1.2 µg/mL) and displayed a significant inhibitory effect (inhibition rate 45.1%) on the release of elastase by human neutrophils at a concentration of 10 µg/mL. We isolated a novel 15C compound, pseudoalteromone B (**1**) ([Figure 1](#marinedrugs-10-01566-f001){ref-type="fig"}), from this microorganism. The structure of **1** was established by spectroscopic methods and this compound displayed a modestly inhibitory effect on the release of elastase by human neutrophils.

![The structure of pseudoalteromone B (**1**).](marinedrugs-10-01566-g001){#marinedrugs-10-01566-f001}

2. Results and Discussion
=========================

Pseudoalteromone B (**1**) was isolated as an oil and had the molecular formula C~15~H~26~O~3~, as determined by HRESIMS (C~15~H~26~O~3~ + Na, *m/z* found 277.1779, calculated 277.1780) indicating three degrees of unsaturation. The IR absorption bands at 3502 and 1706 cm^−1^ were characteristic for the hydroxy and ketone groups.
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^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data for **1**.

  Position   *δ*~H~ (*J* in Hz)             *δ*~C,~ Mult.
  ---------- ------------------------------ ---------------
  1          2.18 s                         31.9, CH~3~
  2                                         211.0, qC
  3a/b       2.58 d (17.2); 2.65 d (17.2)   52.3, CH~2~
  4                                         71.5, qC
  5          1.51 m                         41.9, CH~2~
  6          2.04 m                         22.5, CH~2~
  7          5.09 tq (7.2, 1.2)             124.8, CH
  8                                         134.6, qC
  9          1.96 t (7.2)                   38.8, CH~2~
  10         1.66 quintet (7.2)             21.8, CH~2~
  11         2.37 t (7.2)                   43.0, CH~2~
  12                                        209.1, qC
  13         2.12 s                         29.9, CH~3~
  14         1.22 s                         26.7, CH~3~
  15         1.58 br s                      15.7, CH~3~

The ^1^H and ^13^C NMR data of **1** ([Table 1](#marinedrugs-10-01566-t001){ref-type="table"}) showed the presence of 15 carbon signals, which were identified by the assistance of a DEPT spectrum as four methyls, six sp^3^ methylenes, an sp^2^ methine, an sp^3^ quaternary carbon, and three sp^2^ quaternary carbons including two ketone carbonyls. The ^1^H NMR spectrum of **1** showed a signal of olefinic proton (*δ*~H~ 5.09, 1H, tq, *J* = 7.2, 1.2 Hz, H-7), two acetyl methyls (*δ*~H~ 2.18, 3H, s, H~3~-1; 2.12, 3H, s, H~3~-13), a vinyl methyl (*δ*~H~ 1.58, 3H, br s, H~3~-15), a tertiary methyl attaching at an oxygenated quaternary carbon (*δ*~H~ 1.22, 3H, s, H~3~-14) and six pairs of methylene protons (*δ*~H~ 2.65, 1H, d, *J* = 17.2 Hz; 2.58, 1H, d, *J* = 17.2 Hz, H~2~-3; 2.37, 2H, t, *J* = 7.2 Hz, H~2~-11; 2.04, 2H, m, H~2~-6; 1.96, 2H, t, *J* = 7.2 Hz, H~2~-9; 1.66, 2H, quintet, *J* = 7.2 Hz, H~2~-10; 1.51, 2H, m, H~2~-5).

The constitution of the carbon skeleton of **1** was elucidated initially by the ^1^H--^1^H COSY and HMBC correlations of **1** ([Figure 2](#marinedrugs-10-01566-f002){ref-type="fig"}), it was possible to establish the separate spin systems that map out the proton sequences from H~2~-5/H~2~-6/H-7 and H~2~-9/H~2~-10/H~2~-11. These data, together with the HMBC correlations between H~3~-1/C-2, C-3; H~2~-3/C-2, C-4, C-5; H~2~-5/C-4, C-6; H-7/C-9; H~2~-9/C-7, C-8, C-10, C-11; H~2~-10/C-8, C-9, C-11, C-12; H~2~-11/C-9, C-10, C-12; and H~3~-13/C-11, C-12, permitted elucidation of the main straight carbon skeleton. The vinyl methyl at C-8 was confirmed by the HMBC correlations between H-7, H~2~-9/C-15; and H~3~-15/C-7, C-8, C-9; and further supported by an allylic coupling between H-7 and H~3~-15 (*J* = 1.2 Hz). Based on these data, together with the HMBC correlations between H~3~-14/C-3, C-4, C-5 and H~2~-3, H~2~-5/C-14, the planar structure of **1** was established.

![The ^1^H--^1^H COSY and selective HMBC correlations (protons→quaternary carbons) of **1**.](marinedrugs-10-01566-g002){#marinedrugs-10-01566-f002}

In the NOESY experiment of **1**, a correlation between H-7 with H~2~-9, as well as the lack of correlation between H-7 and H~3~-15, reflected the *E*-configuration of C-7/8 double bond. Furthermore, by comparison of the rotation value of **1** (\[α\]^23^~D~ −20 (*c* 0.03, CHCl~3~)) with that of a known synthetic compound, (*S*)-4-hydroxy-4-methyl-6-phenylhexan-2-one (**2**) (\[α\]^25^~D~ −14.5 (*c* 1.1, CHCl~3~)) ([Figure 3](#marinedrugs-10-01566-f003){ref-type="fig"}) \[[@B5-marinedrugs-10-01566]\], the absolute configuration for the C-4 chiral center of **1** was determined as *S* form as that of **2**. Based on the above findings, the structure of **1** was determined unambiguously.

![The structure of (*S*)-4-hydroxy-4-methyl-6-phenylhexan-2-one (**2**).](marinedrugs-10-01566-g003){#marinedrugs-10-01566-f003}

The *in vitro* cytotoxicity of pseudoalteromone B (**1**) toward HCT116 (human colorectal carcinoma), K-562 (human chronic myelogenous leukemia), HL-60 (human acute promyelocytic leukemia), CCRF-CEM (human T cell acute lymphoblastic leukemia), T-47D (human breast ductal carcinoma), and MDA-MB-231 (human breast adenocarcinoma) cells was tested. Unfortunately, the new compound **1** described herein is not active toward the above cells (all IC~50~ values \> 20 µg/mL). The *in vitro* anti-inflammatory effect of **1** was tested. Pseudoalteromone B (**1**) displayed a modestly inhibitory effect (inhibition rate 20.7%) on the release of elastase by human neutrophils at a concentration of 10 µg/mL.

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotations were measured on a Jasco P-1020 polarimeter. IR spectra were recorded on a Jasco FT/IR-4100 infrared spectrophotometer. The NMR spectra were recorded on a Varian Mercury Plus 400 FT-NMR at 400 MHz for ^1^H and 100 MHz for ^13^C, in CDCl~3~, respectively. Proton chemical shifts were referenced to the residual CHCl~3~ signal (*δ*~H~ 7.26 ppm). ^13^C NMR spectra were referenced to the center peak of CDCl~3~ at *δ*~C~ 77.1 ppm. ESIMS and HRESIMS data were recorded on a Bruker APEX II mass spectrometer. Silica gel (Merck, 230--400 mesh) and Sephadex LH-20 (Amersham Biosciences) were used for column chromatography. TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck); spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating.

3.2. Marine Bacteria Isolation, Culture Conditions and Extract Preparation
--------------------------------------------------------------------------

A marine bacterium number CGH2XX was isolated from soft coral *Lobophytum crassum* that was growing in cultivating tanks equipped with a flow-through sea water system \[[@B4-marinedrugs-10-01566]\]. The bacterium strain CGH2XX was 98.3% identical with *Pseudoalteromonas* sp. H02P24-23 (Genebank accession no. HQ161380) on the basis of 16S rDNA gene sequence. The marine bacterium was cultured in 2.5 L flasks containing 1 L M1 broth (not containing agar) with 80% seawater. Flasks were incubated at 25 °C on a rotatory shaker at 120 rpm. After five days of incubation, extraction of the culture broth (10.0 L) with ethyl acetate (EtOAc, 2 × 10.0 L) yielded 1.71 g of crude extract. The extracts obtained were stored at −20 °C.

3.3. Separation
---------------

Crude extract was separated on Sephadex LH-20 and eluted using a mixture of dichloromethane and methanol (1:1) to yield 17 fractions. Fraction 6 was selected for further study and purified by silica gel, using a mixture of *n*-hexane and EtOAc (2:1) as a mobile phase to afford compound **1** (4.2 mg).

Pseudoalteromone B (**1**): colorless oil; \[α\]^23^~D~ −20 (*c* 0.03, CHCl~3~); IR (neat) ν~max~ 3502, 1706 cm^−1^; ^1^H (CDCl~3~, 400 MHz) and^13^C (CDCl~3~, 100 MHz) NMR data, see [Table 1](#marinedrugs-10-01566-t001){ref-type="table"}; ESIMS: *m/z* 277 (M + Na)^+^; HRESIMS: *m/z* 277.1779 (calcd for C~15~H~26~O~3~ + Na, 277.1780).

3.4. Cytotoxicity Testing
-------------------------

The cytotoxicity of compound **1**was assayed with a modification of the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] colorimetric method. Cytotoxicity assays were carried out according to previously described procedures \[[@B6-marinedrugs-10-01566],[@B7-marinedrugs-10-01566],[@B8-marinedrugs-10-01566]\].

3.5. Elastase Release by Human Neutrophils
------------------------------------------

Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. Elastase release experiments were performed using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate \[[@B9-marinedrugs-10-01566],[@B10-marinedrugs-10-01566],[@B11-marinedrugs-10-01566]\].

4. Conclusions
==============

In a previous study \[[@B4-marinedrugs-10-01566]\], an ubiquinone derivative, pseudoalteromone A, was isolated from *Pseudoalteromonas* sp. CGH2XX, and this compound was found to be cytotoxic toward MOLT-4 (human acute lymphoblastic leukemia) and T-47D (human breast ductal carcinoma) cells (IC~50~ = 3.8, 4.0 µg/mL) and displayed moderately inhibitory effects on the generation of superoxide anion and the release of elastase (inhibition rates 38.0, 20.2%) by human neutrophils at a concentration of 10 µg/mL \[[@B12-marinedrugs-10-01566]\]. However, as described in the beginning of this communication, the organic extract of *Pseudoalteromonas* sp. CGH2XX showed significant cytotoxicity and anti-inflammatory activity. At this stage, the results showed that pseudoalteromone B (**1**) displayed a modestly anti-inflammatory activity and this compound was not cytotoxic toward HCT116, K-562, HL-60, CCRF-CEM, T-47D and MDA-MB-231 cells. We suggested that the other active components exist in the other fractions. The possible activity for pseudoalteromone B (**1**) will be studied if we can get enough material from *Pseudoalteromonas* sp. CGH2XX. Furthermore, to the best of our knowledge, compounds pseudoalteromones A and B, were the first two compounds from the marine bacterium belonging to the genus *Pseudoalteromonas* associated with octocorals.
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